By Rahul Kalvapalle The University of Toronto and Moderna, Inc. – known for its mRNA-based COVID-19 vaccine – plan to work together to develop new tools to prevent and treat infectious diseases. Guided by a partnership framework agreement, the U.S. biotechnology firm...
Originally published on the University of Toronto Rahul Kalvapalle Two projects involving researchers at the University of Toronto and its partner hospitals, each aimed at better understanding and tackling COVID-19, have been awarded a combined total of nearly $2.5...
Originally published on University of Toronto By Paul Fraumeni n an age of COVID-19, the phrase “business as usual” has nearly lost all meaning for Canadians who have seen their lives disrupted in myriad ways. That includes researchers Jean-Philippe...